Co-treatment with troglitazone and a ligand selective for RAR (ATRA, ALART1550), RXR (LG100268), or both receptors (9-cis RA) effectively inhibited clonal growth in several myeloid leukemia cell lines. This evidence concerns the gene RARA and myeloid leukemia.